By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Genitope Corporation 

6900 Dumbarton Circle

Fremont  California  94555  U.S.A.
Phone: 510-284-3000 Fax: 510-284-3100


SEARCH JOBS


Industry
Biotechnology






Company News
Delisting of Securities of Genitope Corporation (GTOP) From the NASDAQ Stock Market 9/15/2008 9:53:30 AM
Genitope Corporation (GTOP) Announces Receipt of Nasdaq Delisting Notice 8/12/2008 11:47:13 AM
Genitope Corporation (GTOP) Announces Receipt of Nasdaq Letter 6/10/2008 11:03:16 AM
Genitope Corporation (GTOP) Announces Receipt of Nasdaq Determination 5/28/2008 11:01:38 AM
Genitope Corporation (GTOP)'s MyVax(R) Personalized Immunotherapy Pivotal Phase 3 Trial Results Available on Company Website 4/9/2008 8:30:13 AM
Genitope Corporation (GTOP) Announces Financial Results for Fourth Quarter and Year Ended December 31, 2007 4/3/2008 8:59:28 AM
Genitope Corporation (GTOP) Announces Receipt of Nasdaq Letter 3/14/2008 9:30:57 AM
Genitope Corporation (GTOP) to Adjourn Special Meeting of Stockholders to March 14, 2008 3/11/2008 9:02:55 AM
Genitope Corporation (GTOP) Stops Cancer Vaccine Program, Looking at Finances 3/11/2008 7:03:56 AM
Genitope Corporation (GTOP) to Adjourn Special Meeting of Stockholders to March 14, 2008 3/10/2008 4:41:03 PM
123456789
//-->